Kenneth Beers leads the operations of INTUS, building upon fifteen years’ experience in life sciences. A chemical engineer by training, Kenneth lead a research group applying computational methods to drugs and biomaterials while on the faculty of MIT. Later switching to industry, Kenneth worked with leading drug companies to develop and commercialize innovative therapies while at McKinsey and as a Partner at boutique consulting firms, where Kenneth led efforts to apply advanced analytics to life sciences.
Jeff Gruen is a leading healthcare executive and strategy advisor. He is an acknowledged leader in the industry and pioneer in digital health innovation. He has previously helped build four innovative healthcare companies. He currently serves as a Senior Partner, helping to lead PwC’s Healthcare Enterprise Strategy Practice. Jeff holds a Master of Business Administration from Harvard Business School and a Doctor of Medicine from Northwestern University’s Honors Program in Medical Education, and he graduated from a pediatric residency at Yale New Haven Hospital. He is a former clinical professor at Harvard Medical School and a board-certified pediatrician, as well as an experienced emergency room physician.
Igor Jurisica is an experienced senior scientist with a demonstrated history of working in the biotechnology industry. Skilled in Computational Biology, Bioinformatics, (big data) analytics, data mining, machine learning, Data Visualization, Image Processing, and high-performance computing.